The relationship between levels of tumor necrosis factor-alpha, interleukin-6, and C-reactive protein in the serum of elderly and acute myocardial infarction
This study aimed to explore the relationship between the serum levels of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and hypersensitive C-reactive protein (hs-CRP) and the prognosis of acute myocardial infarction (AMI) patients after percutaneous coronary intervention (PCI) treatment. A total of 118 early-onset AMI patients who successfully received PCI (in the PCI group, blood samples were collected before PCI, 12, 24, 48 h after PCI, and 90 d follow-up period) and 52 AMI patients who received only cardioangiography (CAG) (in the CAG group, blood samples were collected before CAG, 12, 24, 48 h after CAG, and 9...
Source: Cellular and Molecular Biology - April 28, 2024 Category: Molecular Biology Authors: Jinlong Miao Tao Du Source Type: research
Drug-coated balloon in the treatment of coronary artery de-novo large lesions angiography
Cell Mol Biol (Noisy-le-grand). 2024 Apr 28;70(4):196-201. doi: 10.14715/cmb/2024.70.4.31.ABSTRACTThe superiority of drug-coated balloon (DCB) in treating small vessels, branching lesions, and high-risk bleeding lesions in coronary heart disease patients has been confirmed. However, its safety and efficacy in large vessels are still unclear. We aimed to investigate whether the efficacy of DCB in large vessels is not inferior to that of drug-eluting stent (DES). From November 2019 to April 2022, a total of 88 patients in our hospital who underwent coronary angiography for the first time and decided to receive DCB or DES tre...
Source: Cellular and Molecular Biology - April 28, 2024 Category: Molecular Biology Authors: Xingyou Cai Xin Hong Yuli Wang Yafei Li Guidong Xu Source Type: research
The relationship between levels of tumor necrosis factor-alpha, interleukin-6, and C-reactive protein in the serum of elderly and acute myocardial infarction
This study aimed to explore the relationship between the serum levels of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and hypersensitive C-reactive protein (hs-CRP) and the prognosis of acute myocardial infarction (AMI) patients after percutaneous coronary intervention (PCI) treatment. A total of 118 early-onset AMI patients who successfully received PCI (in the PCI group, blood samples were collected before PCI, 12, 24, 48 h after PCI, and 90 d follow-up period) and 52 AMI patients who received only cardioangiography (CAG) (in the CAG group, blood samples were collected before CAG, 12, 24, 48 h after CAG, and 9...
Source: Mol Biol Cell - April 28, 2024 Category: Molecular Biology Authors: Jinlong Miao Tao Du Source Type: research
Drug-coated balloon in the treatment of coronary artery de-novo large lesions angiography
Cell Mol Biol (Noisy-le-grand). 2024 Apr 28;70(4):196-201. doi: 10.14715/cmb/2024.70.4.31.ABSTRACTThe superiority of drug-coated balloon (DCB) in treating small vessels, branching lesions, and high-risk bleeding lesions in coronary heart disease patients has been confirmed. However, its safety and efficacy in large vessels are still unclear. We aimed to investigate whether the efficacy of DCB in large vessels is not inferior to that of drug-eluting stent (DES). From November 2019 to April 2022, a total of 88 patients in our hospital who underwent coronary angiography for the first time and decided to receive DCB or DES tre...
Source: Mol Biol Cell - April 28, 2024 Category: Molecular Biology Authors: Xingyou Cai Xin Hong Yuli Wang Yafei Li Guidong Xu Source Type: research
The relationship between levels of tumor necrosis factor-alpha, interleukin-6, and C-reactive protein in the serum of elderly and acute myocardial infarction
This study aimed to explore the relationship between the serum levels of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and hypersensitive C-reactive protein (hs-CRP) and the prognosis of acute myocardial infarction (AMI) patients after percutaneous coronary intervention (PCI) treatment. A total of 118 early-onset AMI patients who successfully received PCI (in the PCI group, blood samples were collected before PCI, 12, 24, 48 h after PCI, and 90 d follow-up period) and 52 AMI patients who received only cardioangiography (CAG) (in the CAG group, blood samples were collected before CAG, 12, 24, 48 h after CAG, and 9...
Source: Cellular and Molecular Biology - April 28, 2024 Category: Molecular Biology Authors: Jinlong Miao Tao Du Source Type: research
Drug-coated balloon in the treatment of coronary artery de-novo large lesions angiography
Cell Mol Biol (Noisy-le-grand). 2024 Apr 28;70(4):196-201. doi: 10.14715/cmb/2024.70.4.31.ABSTRACTThe superiority of drug-coated balloon (DCB) in treating small vessels, branching lesions, and high-risk bleeding lesions in coronary heart disease patients has been confirmed. However, its safety and efficacy in large vessels are still unclear. We aimed to investigate whether the efficacy of DCB in large vessels is not inferior to that of drug-eluting stent (DES). From November 2019 to April 2022, a total of 88 patients in our hospital who underwent coronary angiography for the first time and decided to receive DCB or DES tre...
Source: Cellular and Molecular Biology - April 28, 2024 Category: Molecular Biology Authors: Xingyou Cai Xin Hong Yuli Wang Yafei Li Guidong Xu Source Type: research
The relationship between levels of tumor necrosis factor-alpha, interleukin-6, and C-reactive protein in the serum of elderly and acute myocardial infarction
This study aimed to explore the relationship between the serum levels of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and hypersensitive C-reactive protein (hs-CRP) and the prognosis of acute myocardial infarction (AMI) patients after percutaneous coronary intervention (PCI) treatment. A total of 118 early-onset AMI patients who successfully received PCI (in the PCI group, blood samples were collected before PCI, 12, 24, 48 h after PCI, and 90 d follow-up period) and 52 AMI patients who received only cardioangiography (CAG) (in the CAG group, blood samples were collected before CAG, 12, 24, 48 h after CAG, and 9...
Source: Cellular and Molecular Biology - April 28, 2024 Category: Molecular Biology Authors: Jinlong Miao Tao Du Source Type: research
The Current State of Hybrid Coronary Revascularization
Ann Thorac Surg. 2024 Apr 25:S0003-4975(24)00299-6. doi: 10.1016/j.athoracsur.2024.04.010. Online ahead of print.ABSTRACTHybrid coronary revascularization (HCR) combines a minimally invasive surgical approach with percutaneous coronary intervention (PCI) for the treatment of multi-vessel coronary artery disease. Despite decades of use, widespread acceptance has been limited. In this review, we conduct a comparative assessment of HCR in relation to traditional coronary artery bypass graft surgery and multi-vessel PCI. While large scale randomized data is still lacking, numerous studies have demonstrated that HCR may offer b...
Source: The Annals of Thoracic Surgery - April 27, 2024 Category: Cardiovascular & Thoracic Surgery Authors: Robin Willard Joshua Scheinerman Stevan Pupovac Nirav C Patel Source Type: research
The Current State of Hybrid Coronary Revascularization
Ann Thorac Surg. 2024 Apr 25:S0003-4975(24)00299-6. doi: 10.1016/j.athoracsur.2024.04.010. Online ahead of print.ABSTRACTHybrid coronary revascularization (HCR) combines a minimally invasive surgical approach with percutaneous coronary intervention (PCI) for the treatment of multi-vessel coronary artery disease. Despite decades of use, widespread acceptance has been limited. In this review, we conduct a comparative assessment of HCR in relation to traditional coronary artery bypass graft surgery and multi-vessel PCI. While large scale randomized data is still lacking, numerous studies have demonstrated that HCR may offer b...
Source: The Annals of Thoracic Surgery - April 27, 2024 Category: Cardiovascular & Thoracic Surgery Authors: Robin Willard Joshua Scheinerman Stevan Pupovac Nirav C Patel Source Type: research
The Current State of Hybrid Coronary Revascularization
Ann Thorac Surg. 2024 Apr 25:S0003-4975(24)00299-6. doi: 10.1016/j.athoracsur.2024.04.010. Online ahead of print.ABSTRACTHybrid coronary revascularization (HCR) combines a minimally invasive surgical approach with percutaneous coronary intervention (PCI) for the treatment of multi-vessel coronary artery disease. Despite decades of use, widespread acceptance has been limited. In this review, we conduct a comparative assessment of HCR in relation to traditional coronary artery bypass graft surgery and multi-vessel PCI. While large scale randomized data is still lacking, numerous studies have demonstrated that HCR may offer b...
Source: The Annals of Thoracic Surgery - April 27, 2024 Category: Cardiovascular & Thoracic Surgery Authors: Robin Willard Joshua Scheinerman Stevan Pupovac Nirav C Patel Source Type: research
Genetically encoded biocompatible anti-coagulant protein-coated coronary artery stents drive endothelialization
Colloids Surf B Biointerfaces. 2024 Apr 8;238:113908. doi: 10.1016/j.colsurfb.2024.113908. Online ahead of print.ABSTRACTIn response to the critical demand for advancements in coronary artery stents, this study addresses the challenges associated with arterial recoil and restenosis post-angioplasty and the imperative to encourage rapid re-endothelialization for minimizing thrombosis risks. We employed an innovative approach inspired by mussel adhesion, incorporating placental anticoagulant protein (AnnexinV) on stent design. The introduction of a post-translationally modified catecholic amino acid L-3,4-dihydroxyphenylalan...
Source: Colloids and Surfaces - April 27, 2024 Category: Biotechnology Authors: Pandurangan Suryalakshmi Ashokraj Sundarapandian Jebakumar Mercyjayapriya Mohandass Pachaiyappan Prem Suresh Sisila Valappil Mayilvahanan Aarthy Niraikulam Ayyadurai Source Type: research
The Current State of Hybrid Coronary Revascularization
Ann Thorac Surg. 2024 Apr 25:S0003-4975(24)00299-6. doi: 10.1016/j.athoracsur.2024.04.010. Online ahead of print.ABSTRACTHybrid coronary revascularization (HCR) combines a minimally invasive surgical approach with percutaneous coronary intervention (PCI) for the treatment of multi-vessel coronary artery disease. Despite decades of use, widespread acceptance has been limited. In this review, we conduct a comparative assessment of HCR in relation to traditional coronary artery bypass graft surgery and multi-vessel PCI. While large scale randomized data is still lacking, numerous studies have demonstrated that HCR may offer b...
Source: The Annals of Thoracic Surgery - April 27, 2024 Category: Cardiovascular & Thoracic Surgery Authors: Robin Willard Joshua Scheinerman Stevan Pupovac Nirav C Patel Source Type: research
Genetically encoded biocompatible anti-coagulant protein-coated coronary artery stents drive endothelialization
Colloids Surf B Biointerfaces. 2024 Apr 8;238:113908. doi: 10.1016/j.colsurfb.2024.113908. Online ahead of print.ABSTRACTIn response to the critical demand for advancements in coronary artery stents, this study addresses the challenges associated with arterial recoil and restenosis post-angioplasty and the imperative to encourage rapid re-endothelialization for minimizing thrombosis risks. We employed an innovative approach inspired by mussel adhesion, incorporating placental anticoagulant protein (AnnexinV) on stent design. The introduction of a post-translationally modified catecholic amino acid L-3,4-dihydroxyphenylalan...
Source: Colloids and Surfaces - April 27, 2024 Category: Biotechnology Authors: Pandurangan Suryalakshmi Ashokraj Sundarapandian Jebakumar Mercyjayapriya Mohandass Pachaiyappan Prem Suresh Sisila Valappil Mayilvahanan Aarthy Niraikulam Ayyadurai Source Type: research
